Perspectives for cancer immunotherapy mediated by p19Arf plus interferon-beta gene transfer
Clinics; 73 (supl.1), 2018
While cancer immunotherapy has gained much deserved attention in recent years, many areas regarding the optimization of such modalities remain unexplored, including the development of novel approaches and the strategic combination of therapies that target multiple aspects of the cancer-immunity cycle. Ou...
Muerte Celular/genética, Inhibidor p16 de la Quinasa Dependiente de Ciclina/genética, Técnicas de Transferencia de Gen, Terapia Genética/métodos, Inmunoterapia/métodos, Interferón beta/uso terapéutico, Neoplasias/inmunología, Neoplasias/terapia, Sistemas de Lectura/genética, Proteína p14ARF Supresora de Tumor/genética